The Max Planck Research Group of Systems Immunology is a collaborative effort between the Julius Maximilian University of Würzburg (JMU) and the Max Planck Society (MPG) aimed at promoting excellent immunological research. Around 50 researchers from more than 20 countries are working together to understand the basis of a successful immune response against infectious agents, chronic inflammatory diseases, and tumors. Their ultimate goal is to develop new concepts and strategies for vaccines and immunotherapies.
To achieve this, the group is investigating the development and function of the immune system holistically at multiple levels. They are conducting high-resolution analyses of single molecules and cells, examining complex cellular networks within organs, and exploring systemic interactions in the body and with the environment. These research goals align well with the internationally visible research on infectious diseases and immunotherapies at the Würzburg Life Science Campus.
For several years, researchers in Würzburg have been using state-of-the-art single-cell analysis to study individual cells. The new “in situ RNA imaging analyzer” now also enables the visualization of complex disease processes.
The Würzburg-based foundation "Vogel Stiftung" is supporting Anna Lippert`s research project on developing mechano-optimized immune cells with a grant of 20,000 euros
Five professors from the University of Würzburg are among the Highly Cited Researchers 2025, with two of them conducting their research at the university’s Institute for Systems Immunology
After a heart attack, scar tissue impairs cardiac function. A new heart atlas from Würzburg and Freiburg reveals how cells regulate scar formation – offering new insights for improved healing.
The International Max Planck Research School for Immunobiology, Epigenetics and Metabolism (IMPRS-IEM) - a joint international PhD Programme of the Max Planck Institute of Immunobiology and Epigenetics and the University of Freiburg
